The Reply - 22/05/14
Doi : 10.1016/j.amjmed.2014.02.038
James J. DiNicolantonio, PharmD a, Sean C. Lucan, MD, MPH, MS b, Carl J. Lavie, MD c, d, James H. O'Keefe, MD a, e
a Mid America Heart Institute at Saint Luke's Hospital, Kansas City, Mo
b Department of Family and Social Medicine, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, NY
c John Ochsner Heart and Vascular Institute, Ochsner Clinical School-The University of Queensland School of Medicine, New Orleans, La
d Pennington Biomedical Research Center, Baton Rouge, La
e University of Missouri-Kansas City, Kansas City, Mo
Il testo completo di questo articolo è disponibile in PDF.
| Funding: None. |
|
| Conflict of Interest: None. |
|
| Authorship: All authors had access to the data and played a role in writing this manuscript. |
© 2014
Elsevier Inc. Tutti i diritti riservati.
Vol 127 - N° 6
P. e17 - giugno 2014 Ritorno al numero
Articolo precedente
- Dietary Sodium Restriction: Still Searching for the Grains of Truth
- Scott L. Hummel, Alan B. Weder
- Type 2 Myocardial Infarction: The Next Frontier
- Yader Sandoval, Stephen W. Smith, Fred S. Apple
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?